{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:02:42Z","timestamp":1758844962905,"version":"3.44.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.urology.2004.09.030","type":"journal-article","created":{"date-parts":[[2005,2,12]],"date-time":"2005-02-12T07:13:18Z","timestamp":1108192398000},"page":"300-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting"],"prefix":"10.1016","volume":"65","author":[{"given":"C.A.","family":"Mochtar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.L.M.","family":"Kiemeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Laguna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"van Riemsdijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.S.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.M.J.","family":"Debruyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.M.C.H.","family":"de la Rosette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2004.09.030_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0090-4295(02)02371-3","article-title":"BPH","volume":"61","author":"Emberton","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.09.030_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0090-4295(98)00654-2","article-title":"Serum prostate-specific antigen is a powerful predictor of acute urinary retention and the need for surgery in men with clinical benign prostatic hyperplasia","volume":"53","author":"Roehrborn","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.09.030_bib3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0090-4295(99)00232-0","article-title":"Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate","volume":"54","author":"Roehrborn","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.09.030_bib4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1159\/000020356","article-title":"Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention","volume":"38","author":"Marberger","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2004.09.030_bib5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0090-4295(00)00724-X","article-title":"for the PLESS Study Group","volume":"56","author":"Kaplan","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.09.030_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0302-2838(02)00210-5","article-title":"Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes","volume":"42","author":"Roehrborn","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2004.09.030_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000049784","article-title":"EAU guidelines on benign prostatic hyperplasia (BPH)","volume":"40","author":"de la Rosette","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2004.09.030_bib8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0090-4295(01)01402-9","article-title":"Guidelines for the diagnosis and treatment of benign prostatic hyperplasia","volume":"58","author":"Roehrborn","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.09.030_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-5347(01)63011-8","article-title":"5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia","volume":"160","author":"Flanigan","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2004.09.030_bib10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0090-4295(98)00475-0","article-title":"Evaluation of patients with bladder outlet obstruction and mild International Prostate Symptom Score followed up by watchful waiting","volume":"53","author":"Netto","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.09.030_bib11","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0022-5347(05)65189-0","article-title":"Long-term risk of re-treatment of patients using \u03b1-blockers for lower urinary tract symptoms","volume":"167","author":"de la Rosette","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2004.09.030_bib12","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"for the Medical Therapy of Prostatic Symptoms (MTOPS) Research Group","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2004.09.030_bib13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/01.ju.0000076140.68657.fd","article-title":"Long-term safety and efficacy of tamsulosin for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia","volume":"170","author":"Narayan","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2004.09.030_bib14","series-title":"Campbell\u2019s Urology","first-page":"1297","article-title":"Etiology, pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia","author":"Roehrborn","year":"2002"},{"key":"10.1016\/j.urology.2004.09.030_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-5347(01)62083-4","article-title":"Treatment choice for benign prostatic hyperplasia","volume":"161","author":"Stoevelaar","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2004.09.030_bib16","first-page":"373","article-title":"for the ALFECH Study Group","volume":"30","author":"Hansen","year":"1996","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.urology.2004.09.030_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0090-4295(97)00609-2","article-title":"The so-called placebo effect in benign prostatic hyperplasia treatment trials represents partially a conditional regression to the mean induced by censoring","volume":"51","author":"Sech","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.09.030_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0090-4295(98)00655-4","article-title":"Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia","volume":"53","author":"Roehrborn","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.urology.2004.09.030_bib19","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0302-2838(03)00384-1","article-title":"Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia","volume":"44","author":"Mochtar","year":"2003","journal-title":"Eur Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429504010969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429504010969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:39:30Z","timestamp":1758764370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429504010969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0090429504010969"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2004.09.030","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2004.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}